LB

Lavesh Bafna

Active Director Director DIN 08000053
DIN 08000053 First appointment Jan 2018 Primary industry FMCG
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2018
Shareholding value •••• Premium profile

About Lavesh Bafna

Data last updated:

Lavesh Bafna is a Director at Sm Tissues Private Limited (since 2018). The company operates in FMCG. Sm Tissues Private Limited reported revenue of ₹68.7 Lakh (FY 2020).

DIN 08000053
Primary Designation Director
Industry FMCG
First Appointment 12 Jan 2018
Oldest Company Age 8 yrs
Largest company Sm Tissues Private Limited · ₹68.7 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sm Tissues Private Limited U17241GJ2018PTC100516
Director12 Jan 20182018₹68.7 Lakh (FY 2020)Active

Board colleagues of Lavesh Bafna

NameDINCompanyDesignation
Savalchand Singh Arjun08000165Sm Tissues Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sm Tissues Private Limited
Premium access

Shareholding and investment profile for Lavesh Bafna

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lavesh Bafna

Lavesh Bafna currently holds 1 directorship: Sm Tissues Private Limited (Director, since 12 Jan 2018, revenue ₹68.7 Lakh (FY 2020)).

Lavesh Bafna was first appointed on 12 Jan 2018 as Director at Sm Tissues Private Limited.

The current boards of Lavesh Bafna's companies include Savalchand Singh Arjun (Sm Tissues Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available